Siolta Therapeutics develops microbiome analyses to test microbial-based therapeutics for the treatment and prevention of inflammatory diseases. The company was founded in 2016 by Nikole Kimes PhD.
Co-founded in late 2016 by Susan Lynch, Nikole Kimes, and Samir Kaul. Siolta Therapeutics is conducting scientific research aimed at the prevention and treatment of inflammatory diseases, including airway inflammation like Asthma, by using the human microbiome.
Siolta Therapeutics. 97 likes · 7 were here. Siolta Therapeutics is a privately held, venture-backed biotech company focusedbased in San Francisco. It focuses on developing therapeutic microbial consortia to prevent... and treat inflammatory diseases.
The company's lead product candidate is a therapeutic developed from gut microbiome for the prevention and treatment of allergic asthma. The product is also being explored for the treatment of other allergic conditions such as seasonal allergy, food allergy, and atopic dermatitis. Phase 1 clinical trials are ongoing for these target conditions. Future plans also include the development of therapeutics for other chronic inflammatory diseases.
Benjamin M. Fieberger
Co-founder and& CSOChief Scientific Officer
Siolta Therapeutics. 97 likes · 7 were here. Siolta Therapeutics is a biotech company focused on developing therapeutic microbial consortia to prevent...